Revenue
-
Net Income
-$219.9M
▼ 31.4% YoY
EPS
-
Cash
$88.3M
▲ 6.4% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Michaelson Jennifer Chief Scientific Officer | Vest | Mar 5, 2026 | 4.0K | $4.30 | $17K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Mar 5, 2026 | 8.0K | $15.68 | $125K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Feb 25, 2026 | 1.8K | $14.14 | $25K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Feb 24, 2026 | 3.6K | $14.47 | $52K | Form 4 ↗ |
AHMED NADIM President and CEO | Sell | Feb 24, 2026 | 13.5K | $14.47 | $196K | Form 4 ↗ |
Jones Jeffrey Alan Chief Medical Officer | Sell | Feb 24, 2026 | 4.6K | $14.47 | $66K | Form 4 ↗ |
SUMER JACQUELYN L Chief Legal Officer | Sell | Feb 24, 2026 | 3.6K | $14.47 | $52K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Feb 23, 2026 | 1.8K | $13.99 | $25K | Form 4 ↗ |
Jones Jeffrey Alan Chief Medical Officer | Sell | Feb 20, 2026 | 5.0K | $13.62 | $68K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Feb 20, 2026 | 3.7K | $13.62 | $51K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Vest | Feb 20, 2026 | 8.0K | $4.30 | $34K | Form 4 ↗ |
Michaelson Jennifer Chief Scientific Officer | Sell | Feb 20, 2026 | 8.0K | $14.30 | $114K | Form 4 ↗ |
SUMER JACQUELYN L Chief Legal Officer | Sell | Feb 20, 2026 | 3.7K | $13.62 | $51K | Form 4 ↗ |
AHMED NADIM President and CEO | Sell | Feb 20, 2026 | 16.4K | $13.62 | $223K | Form 4 ↗ |
Fenton Mary Kay Chief Financial Officer | Sell | Feb 20, 2026 | 4.4K | $13.62 | $60K | Form 4 ↗ |